Inhibitory effects of desvenlafaxine on gastric slow waves, antral contractions, and gastric accommodation mediated via the sympathetic mechanism in dogs

American Journal of Physiology - Gastrointestinal and Liver Physiology

Volumn 301, Issue 4, 2011, Pages

  Dai, Fei ^a   Lei, Yong ^a   Chen, Jiande D Z ^a,b  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b University of Texas Medical Branch School of Medicine   (United States)

Author keywords

Antidepressants; Desvenlafaxine succinate; Gastrointestinal motility

Indexed keywords

DESVENLAFAXINE; PROPRANOLOL;

ARTICLE; BALLOON; BAROSTAT; CANNULA; CATHETER; CONTROLLED STUDY; DOG; ELECTRODE; FEMALE; HEART RATE VARIABILITY; MANOMETER; MUSCLE TONE; NONHUMAN; POSTPRANDIAL STATE; PRIORITY JOURNAL; SPECTROSCOPY; STOMACH ANTRUM; STOMACH FUNDUS; STOMACH MUSCLE; SYMPATHETIC TONE;

ANIMALS; ANTIDEPRESSIVE AGENTS; CYCLOHEXANOLS; DOGS; GASTRIC EMPTYING; GASTROINTESTINAL MOTILITY; NEUROTRANSMITTER UPTAKE INHIBITORS; PYLORIC ANTRUM; STOMACH;

EID: 80053189696     PISSN: 01931857     EISSN: 15221547     Source Type: Journal    
DOI: 10.1152/ajpgi.00044.2011     Document Type: Article

References (58)

1. Ahrens T, Frankhauser P, Lederbogen F, Deuschle M. Effect of singledose sertraline on the hypothalamus-pituitary-adrenal system, autonomic nervous system, and platelet function. J Clin Psychopharmacol 27: 602-606, 2007.
2. Archer DF, Dupont CM, Constantine GD, Pickar JH, Olivier S; Study 319 Investigators. Desvenlafaxine for the treatment of vasomotor symptoms associated with menopause: a double-blind, randomized, placebocontrolled trial of efficacy and safety. Am J Obstet Gynecol 200: 238.e1-238.e10, 2009.
3. Bouras EP, Talley NJ, Camilleri M, Burton DD, Heckman MG, Crook JE, Richelson E. Effects of amitriptyline on gastric sensorimotor function and postprandial symptoms in healthy individuals: a randomized, doubleblind, placebo-controlled trial. Am J Gastroenterol 103: 2043-2050, 2008.
4. Chen JD, McCallum RW, Richards R. Frequency components of the electrogastrogram and their correlations with gastrointestinal motility. Med Biol Eng Comput 31: 60-67, 1993.
5. Chen JD, Pan J, McCallum RW. Clinical significance of gastric myoelectrical dysrhythmias. Dig Dis 13: 275-290, 1995.
6. Chen JD, Stewart WR, McCallum RW. Spectral analysis of episodic rhythmic variations in the cutaneous electrogastrogram. IEEE Trans Biomed Eng 40: 128-135, 1993.
7. Chial HJ, Camilleri M, Burton D, Thomforde G, Olden KW, Stephens D. Selective effects of serotonergic psychoactive agents on gastrointestinal functions in health. Am J Physiol Gastrointest Liver Physiol 284: G130-G137, 2003.
8. Chial HJ, Camilleri M, Ferber I, Delgado-Aros S, Burton D, McKinzie S, Zinsmeister AR. Effects of venlafaxine, buspirone, and placebo on colonic sensorimotor functions in healthy humans. Clin Gastroenterol Hepatol 1: 211-218, 2003.
9. Choung RS, Cremonini F, Thapa P, Zinsmeister AR, Talley NJ. The effect of short-term, low-dose tricyclic and tetracyclic antidepressant treatment on satiation, postnutrient load gastrointestinal symptoms and gastric emptying: a double-blind, randomized, placebo-controlled trial. Neurogastroenterol Motil 20: 220-227, 2008.
10. Clouse RE, Lustman PJ, Geisman RA, Alpers DH. Antidepressant therapy in 138 patients with irritable bowel syndrome: a five-year clinical experience. Aliment Pharmacol Ther 8: 409-416, 1994.
11. Creed F, Fernandes L, Guthrie E, Palmer S, Ratcliffe J, Read N, Rigby C, Thompson D, Tomenson B. The cost-effectiveness of psychotherapy and paroxetine for severe irritable bowel syndrome. Gastroenterology 124: 303-317, 2003.
12. Davidson J, Watkins L, Owens M, Krulewicz S, Connor K, Carpenter D, Krishnan R, Nemeroff C. Effects of paroxetine and venlafaxine XR on heart rate variability in depression. J Clin Psychopharmacol 25: 480-484, 2005.
13. Deecher DC, Beyer CE, Johnston G, Bray J, Shah S, Abou-Gharbia M, Andree TH. Desvenlafaxine succinate: a new serotonin and norepinephrine reuptake inhibitor. J Pharmacol Exp Ther 318: 657-665, 2006.
14. DeMartinis NA, Yeung PP, Entsuah R, Manley AL. A double-blind, placebo-controlled study of the efficacy and safety of desvenlafaxine succinate in the treatment of major depressive disorder. J Clin Psychiatry 68: 677-688, 2007.
15. Desai KM, Sessa WC, Vane JR. Involvement of nitric oxide in the reflex relaxation of the stomach to accommodate food or fluid. Nature 35: 477-479, 1991.
16. Feiger AD, Tourian KA, Rosas GR, Padmanabhan SK. A placebocontrolled study evaluating the efficacy and safety of flexible-dose desvenlafaxine treatment in outpatients with major depressive disorder. CNS Spectr 14: 41-50, 2009.
17. Ford AC, Talley N, Schoenfeld PS, Quigley EM, Moayyedi P. Efficacy of antidepressants and psychological therapies in irritable bowel syndrome: systematic review and meta-analysis. Gut 58: 367-378, 2009.
18. Haug TT, Svebak S, Wilhelmsen I, Berstad A, Ursin H. Psychological factors and somatic symptoms in functional dyspepsia. A comparison with duodenal ulcer and healthy controls. J Psychosom Res 38: 281-291, 1994.
19. Huikuri HV, Raatikainen MJ, Moerch-Joergensen R, Hartikainen J, Virtanen V, Boland J, Anttonen O, Hoest N, Boersma LV, Platou ES, Messier MD, Bloch-Thomsen PE. Prediction of fatal or near-fatal cardiac arrhythmia events in patients with depressed left ventricular function after an acute myocardial infarction. Eur Heart J 30: 689-698, 2009.
20. Jackson JL, O'Malley PG, Tomkins G, Balden E, Santoro J, Kroenke K. Treatment of functional gastrointestinal disorders with antidepressant medications: a meta-analysis. Am J Med 108: 65-72, 2000.
21. Jakobsen J, Hauksson P, Vestergaard P. Heart rate variation in patients treated with antidepressants. An index of anticholinergic effects? Psychopharmacology 84: 544-548, 1984.
22. Kemp AH, Quintana DS, Gray MA, Felmingham KL, Brown K, Gatt JM. Impact of depression and antidepressant treatment on heart rate variability: a review and meta-analysis. Biol Psychiatry 67: 1067-1074, 2010.
23. Kim CH, Azpiroz F, Malagelada JR. Characteristics of spontaneous and drug-induced gastric dysrhythmias in a chronic canine model. Gastroenterology 90: 421-427, 1986.
24. Lederbogen F, Gernoth C, Weber B, Colla M, Kniest A, Heuser I, Deuschle M. Antidepressive treatment with amitriptyline and paroxetine: comparable effects on heart rate variability. J Clin Psychopharmacol 21: 238-239, 2001.
25. Liebowitz MR, Manley AL, Padmanabhan SK, Ganguly R, Tummala R, Tourian KA. Efficacy, safety, and tolerability of desvenlafaxine 50 mg/day and 100 mg/day in outpatients with major depressive disorder. Curr Med Res Opin 24: 1877-1890, 2008.
26. Lourenco MT, Kennedy SH. Desvenlafaxine in the treatment of major depressive disorder. Neuropsychiatr Dis Treat 5: 127-136, 2009.
27. Lynch ME. Antidepressants as analgesics: a review of randomized controlled trials. J Psychiatry Neurosci 26: 30-36, 2001.
28. McFarlane A, Kamath MV, Fallen EL, Malcolm V, Cherian F, Norman G. Effect of sertraline on the recovery rate of cardiac autonomic function in depressed patients after acute myocardial infarction. Am Heart J 142: 617-623, 2001.
29. Meulemans AL, Helsen LF, Schuurkes JA. The role of nitric oxide (NO) in 5-HT-induced relaxations of the guinea-pig stomach. Naunyn Schmiedebergs Arch Pharmacol 348: 424-430, 1993.
30. Min KB, Min JY, Paek D, Cho SI. The impact of the components of metabolic syndrome on heart rate variability: using the NCEP-ATP III and IDF definitions. Pacing Clin Electrophysiol 31: 584-591, 2008.
31. Ouyang H, Xing J, Chen JDZ. Tachygastria induced by gastric electrical stimulation is mediated via alpha- and beta-adrenergic pathway and inhibits antral motility in dogs. Neurogastroenterol Motil 17: 846-853, 2005.
32. Ouyang H, Yin J, Wang Z, Pasricha PJ, Chen JDZ. Electroacupuncture accelerates gastric emptying in association with changes in vagal activity. Am J Physiol Gastrointest Liver Physiol 282: G390-G396, 2002.
33. Pae CU. Desvenlafaxine: a new antidepressant or just another one? Expert Opin Pharmacother 10: 875-887, 2009.
34. Pae CU, Park MH, Marks DM, Han C, Patkar AA, Masand PS. Desvenlafaxine, a serotonin-norepinephrine uptake inhibitor for major depressive disorder, neuropathic pain and the vasomotor symptoms associated with menopause. Curr Opin Investig Drugs 10: 75-90, 2009.
35. Perry R, Cassagnol M. Desvenlafaxine: a new serotonin-norepinephrine reuptake inhibitor for the treatment of adults with major depressive disorder. Clin Ther 31: 1374-1404, 2009.
36. Qian LW, Pasricha J, Chen JDZ. Origins and patterns of spontaneous and drug-induced canine gastric myoelectrical dysrhythmias. Dig Dis Sci 48: 508-515, 2003.
37. Rechlin T. Effects of psychopharmacologic therapy on heart rate variation. Nervenarzt 66: 678-685, 1995.
38. Richelson E. Pharmacology of antidepressants in use in the United States. J Clin Psychiatry 43: 4-13, 1982.
39. Roose SP, Laghrissi-Thode F, Kennedy JS, Nelson JC, Bigger JT Jr, Pollock BG, Gaffney A, Narayan M, Finkel MS, McCafferty J, Gergel I. Comparison of paroxetine and nortriptyline in depressed patients with ischemic heart disease. JAMA 279: 287-291, 1998.
40. Schepper HU, Cremonini F, Chitkara D, Camilleri M. Assessment of gastric accommodation: overview and evaluation of current methods. Neurogastroenterol Motil 16: 275-285, 2004.
41. Siepmann T, Ziemssen T, Mueck-Weymann M, Kirch W, Siepmann M. The effects of venlafaxine on autonomic functions in healthy volunteers. J Clin Psychopharmacol 27: 687-691, 2007.
42. Song G, Hou X, Yang B, Liu J, Qian W, Chen JD. Two-channel gastric electrical stimulation accelerates delayed gastric emptying induced by vasopressin. Dig Dis Sci 50: 662-668, 2005.
43. Sun WM, Smout A, Malbert C, Edelbroek MA, Jones K, Dent J, Horowitz M. Relationship between surface electrogastrography and antropyloric pressure. Am J Physiol 31: G424-G430, 1995.
44. Tack J, Broekaert D, Coulie B, Fischler B, Janssens J. Influence of the selective serotonin re-uptake inhibitor, paroxetine, on gastric sensorimotor function in humans. Aliment Pharmacol Ther 17: 603-608, 2003.
45. Tack J, Demedts I, Meulemans A, Schuurkes J, Janssens J. Role of nitric oxide in the gastric accommodation reflex and in meal induced satiety in humans. Gut 51: 219-224, 2002.
46. Tack J, Piessevaux H, Coulie B, Caenepeel P, Janssens J. Role of impaired gastric accommodation to a meal in functional dyspepsia. Gastroenterology 115: 1346-1352, 1998.
47. Talley NJ, Stanghellini V, Heading R, Koch KL, Malagelada JR, Tytgat GNJ. Functional gastroduodenal disorders: a working team report for the Rome II consensus on functional gastrointestinal disorders. Gut 45, Suppl 2: II37-II42, 1999.
48. Tanaka T, Kendrick ML, Zyromski NJ, Meile T, Sarr MG. Vagal innervation modulates motor pattern but not initiation of canine gastric migrating motor complex. Am J Physiol Gastrointest Liver Physiol 281: G283-G292, 2001.
49. Teschemacher AG. Real-time measurements of noradrenaline release in periphery and central nervous system. Auton Neurosci 117: 1-8, 2005.
50. Thumshirn M, Camilleri M. Evaluation of gastrointestinal autonomic function. In: Gastrointestinal Function in Diabetes Mellitus, edited by Horowitz M and Samsom M. London: John Wiley & Sons, 2004, p. 323-337.
51. Tsukada F, Nagura Y, Abe S, Sato N, Ohkubo Y. Effect of restraint and footshock stress and norepinephrine treatment on gastric emptying in rats. Biol Pharm Bull 26: 368-370, 2003.
52. Tsukada F, Sawamura K, Kohno H, Ohkubo Y. Mechanism of inhibition of small intestinal motility by restraint stress differs from that with norepinephrine treatment in rats. Biol Pharm Bull 25: 122-124, 2002.
53. Tucker P, Adamson P, Miranda R Jr, Scarborough A, Williams D, Groff J, McLean H. Paroxetine increases heart rate variability in panic disorder. J Clin Psychopharmacol 17: 370-376, 1997.
54. Tulen JH, Bruijn JA, de Man KJ, Pepplinkhuizen L, van den Meiracker AH, Man in't Veld AJ. Cardiovascular variability in major depressive disorder and effects of imipramine or mirtazapine (Org 3770). J Clin Psychopharmacol 16: 135-145, 1996.
55. van Kerkhoven LA, Laheij RJ, Aparicio N, De Boer WA, Van den Hazel S, Tan AC, Witteman BJ, Jansen JB. Effect of the antidepressant venlafaxine in functional dyspepsia: a randomized, double-blind, placebocontrolled trial. Clin Gastroenterol Hepatol 6: 746-752, 2008.
56. van Zyl LT, Hasegawa T, Nagata K. Effects of antidepressant treatment on heart rate variability in major depression: a quantitative review. Biopsychosoc Med 2: 12, 2008.
57. Xing JH, Chen JDZ. Effects and mechanisms of long-pulse gastric electrical stimulation on canine gastric tone and accommodation. Neurogastroenterol Motil 18: 136-143, 2006.
58. Yeragani V, Pesce V, Jayaraman A, Roose S. Major depression with ischemic heart disease effects of paroxetine and nortriptyline on longterm heart rate variability measures. Biol Psychiatry 52: 418-429, 2000